The Race for the Next Big Weight-Loss Drug Is On—and China Wants In
SHANGHAI—Chinese biotech companies, rapidly evolving from manufacturers of low-end generic drugs to serious competitors to American pharma giants, are training their sights on one of the most lucrative medicines: GLP-1s.














